Expression of eukaryotic translation initiation factors 4E and 2 alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung
Ib. Rosenwald et al., Expression of eukaryotic translation initiation factors 4E and 2 alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung, CANCER, 92(8), 2001, pp. 2164-2171
Background. When resting cells are stimulated by growth factors, an increas
e in protein synthesis follows that depends in part on two key eukaryotic t
ranslation initiation factors, 4E and 2 alpha (eIF-4E and eIF-2 alpha, resp
ectively). In the normal cell, expression and activity of both factors are
increased transiently, whereas they become elevated constitutively in oncog
ene-transformed cultured cells, and overexpression of either initiation fac
tor in rodent cells makes them tumorigenic. In this study, the authors inve
stigated an association between the expression of these translation initiat
ion factors and lung carcinogenesis.
Methods. The authors analyzed the expression of the protein synthesis initi
ation factors eIF-4E and eIF-2 alpha by immunohistochemistry in bronchioloa
lveolar (BA) and squamous cell (SC) carcinomas of the lung. Western blot an
alysis was performed to validate the specificity of antibodies in detecting
their cognate proteins.
Results. Both eIF-4E and eIF-2 alpha were increased frequently in BA carcin
omas, whereas only rarely did SC carcinomas demonstrate elevation of these
translation initiation factors. An analysis of cyclin D1 expression did not
show a strict correlation with the expression of eIF-4E and eIF-2 alpha.
Conclusions. Increased expression of either one or both translation initiat
ion factors may facilitate accelerated grow-th and division of neoplastic c
ells in BA carcinoma of the lung. However, the current findings suggest a p
ossibility that increased cell growth and proliferation in SC carcinoma may
be achieved through a mechanism independent of increases in eIF-4E and eIF
-2 alpha expression. Cancer 2001;92:2164-71. (C) 2001 American Cancer Socie
ty.